{"title":"心脏病学中基于电子健康记录的研究:进行实用试验的时候到了。","authors":"Daniel Seabra, Afonso Oliveira, Cristina Gavina","doi":"10.1016/j.repc.2024.12.007","DOIUrl":null,"url":null,"abstract":"<p><p>Randomized clinical trials (RCTs) are the cornerstone of evidence-based medicine, as they minimize bias in the allocation of interventions. However, RCTs performed in a very selective population and overcontrolled conditions may impair the generalizability of results. Moreover, increasing running costs and regulatory complexity compromise the conduct of these studies. The need for pragmatic trial designs, with streamlined procedures and low running costs, will shape the short-term future of research in RCTs. Electronic health records (EHR) are routinely collected as part of the treatment of patients. These provide large amounts of data at no significant cost. The so-called \"real-world data\" are often used in observational studies with unavoidable bias. However, by combining the randomization of large numbers of patients with the data collected in EHRs, it is possible to answer very relevant clinical questions at a relatively low cost. In this review, we describe how the integration of EHR and randomization is fostering innovative approaches to the conduct of RCTs in Cardiology.</p>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electronic health records-based research in Cardiology: The time has come for pragmatic trials.\",\"authors\":\"Daniel Seabra, Afonso Oliveira, Cristina Gavina\",\"doi\":\"10.1016/j.repc.2024.12.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Randomized clinical trials (RCTs) are the cornerstone of evidence-based medicine, as they minimize bias in the allocation of interventions. However, RCTs performed in a very selective population and overcontrolled conditions may impair the generalizability of results. Moreover, increasing running costs and regulatory complexity compromise the conduct of these studies. The need for pragmatic trial designs, with streamlined procedures and low running costs, will shape the short-term future of research in RCTs. Electronic health records (EHR) are routinely collected as part of the treatment of patients. These provide large amounts of data at no significant cost. The so-called \\\"real-world data\\\" are often used in observational studies with unavoidable bias. However, by combining the randomization of large numbers of patients with the data collected in EHRs, it is possible to answer very relevant clinical questions at a relatively low cost. In this review, we describe how the integration of EHR and randomization is fostering innovative approaches to the conduct of RCTs in Cardiology.</p>\",\"PeriodicalId\":48985,\"journal\":{\"name\":\"Revista Portuguesa De Cardiologia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Portuguesa De Cardiologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.repc.2024.12.007\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Portuguesa De Cardiologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.repc.2024.12.007","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Electronic health records-based research in Cardiology: The time has come for pragmatic trials.
Randomized clinical trials (RCTs) are the cornerstone of evidence-based medicine, as they minimize bias in the allocation of interventions. However, RCTs performed in a very selective population and overcontrolled conditions may impair the generalizability of results. Moreover, increasing running costs and regulatory complexity compromise the conduct of these studies. The need for pragmatic trial designs, with streamlined procedures and low running costs, will shape the short-term future of research in RCTs. Electronic health records (EHR) are routinely collected as part of the treatment of patients. These provide large amounts of data at no significant cost. The so-called "real-world data" are often used in observational studies with unavoidable bias. However, by combining the randomization of large numbers of patients with the data collected in EHRs, it is possible to answer very relevant clinical questions at a relatively low cost. In this review, we describe how the integration of EHR and randomization is fostering innovative approaches to the conduct of RCTs in Cardiology.
期刊介绍:
The Portuguese Journal of Cardiology, the official journal of the Portuguese Society of Cardiology, was founded in 1982 with the aim of keeping Portuguese cardiologists informed through the publication of scientific articles on areas such as arrhythmology and electrophysiology, cardiovascular surgery, intensive care, coronary artery disease, cardiovascular imaging, hypertension, heart failure and cardiovascular prevention. The Journal is a monthly publication with high standards of quality in terms of scientific content and production. Since 1999 it has been published in English as well as Portuguese, which has widened its readership abroad. It is distributed to all members of the Portuguese Societies of Cardiology, Internal Medicine, Pneumology and Cardiothoracic Surgery, as well as to leading non-Portuguese cardiologists and to virtually all cardiology societies worldwide. It has been referred in Medline since 1987.